|
|
Previous Article | Table of Contents | Next Article 
Engraftment and Retroviral Marking of CD34+ and
CD34+CD38 Human Hematopoietic Progenitors
Assessed in Immune-Deficient Mice
Mo A. Dao,
Ami J. Shah,
Gay M. Crooks, and
Jan A. Nolta
From the Division of Research Immunology/Bone Marrow Transplantation,
Childrens Hospital Los Angeles, Los Angeles, CA, and University of
Southern California School of Medicine, Department of Pediatrics, Los
Angeles, CA.
Retroviral-mediated transduction of human hematopoietic stem cells
to provide a lifelong supply of corrected progeny remains the most
daunting challenge to the success of human gene therapy. The paucity of
assays to examine transduction of pluripotent human stem cells hampers
progress toward this goal. By using the beige/nude/xid (bnx)/hu immune-deficient mouse xenograft system, we
compared the transduction and engraftment of human CD34+
progenitors with that of a more primitive and quiescent subpopulation, the CD34+CD38 cells. Comparable extents of
human engraftment and lineage development were obtained from 5 × 105 CD34+ cells and 2,000 CD34+CD38 cells. Retroviral marking of
long-lived progenitors from the CD34+ populations was
readily accomplished, but CD34+CD38 cells
capable of reconstituting bnx mice were resistant to transduction. Extending the duration of transduction from 3 to 7 days
resulted in low levels of transduction of
CD34+CD38 cells. Flt3 ligand was required
during the 7-day ex vivo culture to maintain the ability of the cells
to sustain long-term engraftment and hematopoiesis in the mice.
Blood, Vol. 91 No. 4 (February 15), 1998:
pp. 1243-1255
© 1998 by The American Society of Hematology.

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
M. A. Dao, J. Arevalo, and J. A. Nolta
Reversibility of CD34 expression on human hematopoietic stem cells that retain the capacity for secondary reconstitution
Blood,
January 1, 2003;
101(1):
112 - 118.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. A. Dao, J. Hwa, and J. A. Nolta
Molecular mechanism of transforming growth factor beta -mediated cell-cycle modulation in primary human CD34+ progenitors
Blood,
January 15, 2002;
99(2):
499 - 506.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. C. Tsark, M. A. Dao, X. Wang, K. Weinberg, and J. A. Nolta
IL-7 Enhances the Responsiveness of Human T Cells That Develop in the Bone Marrow of Athymic Mice
J. Immunol.,
January 1, 2001;
166(1):
170 - 181.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Glimm, I.-H. Oh, and C. J. Eaves
Human hematopoietic stem cells stimulated to proliferate in vitro lose engraftment potential during their S/G2/M transit and do not reenter G0
Blood,
December 15, 2000;
96(13):
4185 - 4193.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. S. Rosler, J. E. Brandt, J. Chute, and R. Hoffman
An in vivo competitive repopulation assay for various sources of human hematopoietic stem cells
Blood,
November 15, 2000;
96(10):
3414 - 3421.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. L. MacKenzie, N. R. Hackett, R. G. Crystal, and M. A. S. Moore
Adenoviral vector-mediated gene transfer to primitive human hematopoietic progenitor cells: assessment of transduction and toxicity in long-term culture
Blood,
July 1, 2000;
96(1):
100 - 108.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Schiedlmeier, K. Kuhlcke, H. G. Eckert, C. Baum, W. J. Zeller, and S. Fruehauf
Quantitative assessment of retroviral transfer of the human multidrug resistance 1 gene to human mobilized peripheral blood progenitor cells engrafted in nonobese diabetic/severe combined immunodeficient mice
Blood,
February 15, 2000;
95(4):
1237 - 1248.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Verhasselt, T. Kerre, E. Naessens, D. Vanhecke, M. De Smedt, B. Vandekerckhove, and J. Plum
Thymic Repopulation by CD34+ Human Cord Blood Cells After Expansion in Stroma-Free Culture
Blood,
December 1, 1999;
94(11):
3644 - 3652.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Rosenzweig, T.J. MacVittie, D. Harper, D. Hempel, R.L. Glickman, R.P. Johnson, A.M. Farese, N. Whiting-Theobald, G.F. Linton, G. Yamasaki, et al.
Efficient and Durable Gene Marking of Hematopoietic Progenitor Cells in Nonhuman Primates After Nonablative Conditioning
Blood,
October 1, 1999;
94(7):
2271 - 2286.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. I. Rebel, M. Tanaka, J.-S. Lee, S. Hartnett, M. Pulsipher, D. G. Nathan, R. C. Mulligan, and C. A. Sieff
One-Day Ex Vivo Culture Allows Effective Gene Transfer Into Human Nonobese Diabetic/Severe Combined Immune-Deficient Repopulating Cells Using High-Titer Vesicular Stomatitis Virus G Protein Pseudotyped Retrovirus
Blood,
April 1, 1999;
93(7):
2217 - 2224.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. S. Case, M. A. Price, C. T. Jordan, X. J. Yu, L. Wang, G. Bauer, D. L. Haas, D. Xu, R. Stripecke, L. Naldini, et al.
Stable transduction of quiescent CD34+CD38- human hematopoietic cells by HIV-1-based lentiviral vectors
PNAS,
March 16, 1999;
96(6):
2988 - 2993.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. B. van Hennik, M. M.A. Verstegen, M. F.A. Bierhuizen, A. Limon, A. W. Wognum, J. A. Cancelas, J. Barquinero, R. E. Ploemacher, and G. Wagemaker
Highly Efficient Transduction of the Green Fluorescent Protein Gene in Human Umbilical Cord Blood Stem Cells Capable of Cobblestone Formation in Long-Term Cultures and Multilineage Engraftment of Immunodeficient Mice
Blood,
December 1, 1998;
92(11):
4013 - 4022.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. J. Schilz, G. Brouns, O. G. Ottmann, D. Hoelzer, A. A. Fauser, A. J. Thrasher, and M. Grez
High Efficiency Gene Transfer to Human Hematopoietic SCID-Repopulating Cells Under Serum-Free Conditions
Blood,
November 1, 1998;
92(9):
3163 - 3171.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. A. Dao, N. Taylor, and J. A. Nolta
Reduction in levels of the cyclin-dependent kinase inhibitor p27kip-1 coupled with transforming growth factor beta neutralization induces cell-cycle entry and increases retroviral transduction of primitive human hematopoietic cells
PNAS,
October 27, 1998;
95(22):
13006 - 13011.
[Abstract]
[Full Text]
[PDF]
|
 |
|
| |